MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 130 filers reported holding MERSANA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $59,235 | -61.4% | 46,642 | 0.0% | 0.00% | -100.0% |
Q2 2023 | $153,452 | -20.0% | 46,642 | 0.0% | 0.00% | 0.0% |
Q1 2023 | $191,699 | -29.9% | 46,642 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $273,322 | -13.3% | 46,642 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $315,300 | +77.3% | 46,642 | +21.2% | 0.00% | +200.0% |
Q2 2022 | $177,847 | +78.5% | 38,495 | +54.1% | 0.00% | 0.0% |
Q1 2022 | $99,642 | -40.7% | 24,973 | -7.6% | 0.00% | 0.0% |
Q4 2021 | $168,083 | +2.6% | 27,023 | +55.6% | 0.00% | -50.0% |
Q3 2021 | $163,780 | -53.3% | 17,368 | -32.7% | 0.00% | -33.3% |
Q2 2021 | $350,704 | +2.5% | 25,825 | +22.1% | 0.00% | 0.0% |
Q1 2021 | $342,191 | -43.9% | 21,149 | -7.7% | 0.00% | -50.0% |
Q4 2020 | $609,795 | +42.9% | 22,916 | 0.0% | 0.01% | +20.0% |
Q3 2020 | $426,696 | -12.2% | 22,916 | +10.3% | 0.01% | -16.7% |
Q2 2020 | $486,229 | +354.6% | 20,779 | +13.3% | 0.01% | +200.0% |
Q1 2020 | $106,951 | – | 18,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |